| Literature DB >> 722727 |
D T Witiak, H J Lee, H D Goldman, B S Zwilling.
Abstract
The synthesis for cis-4,4' (1,2-cyclopropanediyl)bis(2,6-piperazinedione) (cis-3) is discussed. Stereoselective effects on metastases of cis-3 and the previously reported trans-2 isomer were compared to conformationally mobile ICRF-159 using a Syrian hamster lung adenocarcinoma (LG1002). Whereas ICRF-159 and cis-3 significantly inhibited lung metastases the trans-2 isomer significantly increased the number of metastatic nodules in the lung. Thus, these studies have revealed that, at least in one tumor model, antimetastatic activity can be separated from metastatic potentiating activity by controlling drug geometry.Entities:
Mesh:
Substances:
Year: 1978 PMID: 722727 DOI: 10.1021/jm00210a004
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446